Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
102.3 USD | -0.06% |
|
-.--% | -5.72% |
02:04pm | Redburn Atlantic Initiates Arkema at Buy | MT |
05-14 | Arkema: collaboration with ProLogium in batteries | CF |
Strengths
- The company's attractive earnings multiples are brought to light by a P/E ratio at 10.52 for the current year.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company's share price in relation to its net book value makes it look relatively cheap.
- This company will be of major interest to investors in search of a high dividend stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-5.72% | 6.78B | - | ||
+2.74% | 103B | A- | ||
-11.86% | 59.25B | A- | ||
+68.10% | 47.15B | B | ||
+11.66% | 37.09B | B | ||
+0.42% | 31.09B | A- | ||
+4.59% | 18.82B | B- | ||
+14.08% | 16.97B | C+ | ||
+7.06% | 13.67B | B- | ||
-8.41% | 12.77B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- AKE Stock
- ARKAF Stock
- Ratings Arkema